18F-NaF PET/CT is indicated for diagnostic imaging of bone to define altered osteogenic
areas of activity. It provides high-resolution, high-contrast images of the skeletal tissue and …

In the 1970s, 18F-labeled sodium fluoride (18F-NaF), one of the most ubiquitous positron-
emitting radiopharmaceuticals, was briefly used for skeletal scintigraphy before the …

Bone scintigraphy is used to help diagnose conditions such as malignancy, inflammation
and fracture. It provides functional imaging to visualise bone metabolism which radiograph …

We describe the role of 18F-sodium fluoride (18F-NaF) PET/CT bone scanning in the
staging of breast and prostate cancer. 18F-NaF PET was initially utilized as a bone scanning …

[Imaging of the normal skeletal system with 18F Na-PET compared with conventional skeletal
scintigraphy using Tc99m-MDP]. - Abstract - Europe PMC Sign in | Create an account …

Abstract Bone scintigraphy using $^{99m} $ Tc-labeled phosphate agents has long been the
standard evaluation method for whole skeletal system. However, recent shortage of $^{99m} …

18F-Fluoride PET/CT was performed on 44 oncologic patients to evaluate its diagnostic
accuracy in assessing malignant osseous involvement and in differentiating malignant from …

597 Objectives: F-18 Fluoride PET-CT is the most sensitive imaging modality for detection of
malignant bone involvement. The aim of this study was to examine if semiquantitative …

Although 18F-labeled NaF was the first widely used agent for skeletal scintigraphy, it quickly
fell into disuse after the introduction of 99mTc-labeled bone-imaging agents. Recent …

The skeleton is one of the most common sites for metastatic disease, particularly from breast
and prostate cancer. Bone metastases are associated with considerable morbidity, and …